CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 73 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $6,000 | +20.0% | 1,394 | 0.0% | 0.00% | – |
Q1 2022 | $5,000 | 0.0% | 1,394 | -6.6% | 0.00% | – |
Q4 2021 | $5,000 | 0.0% | 1,493 | -1.3% | 0.00% | – |
Q3 2021 | $5,000 | -16.7% | 1,512 | +1.4% | 0.00% | – |
Q2 2021 | $6,000 | -25.0% | 1,491 | -1.4% | 0.00% | – |
Q1 2021 | $8,000 | -38.5% | 1,512 | +51.2% | 0.00% | – |
Q4 2020 | $13,000 | +30.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2020 | $10,000 | +233.3% | 1,000 | +400.0% | 0.00% | – |
Q4 2018 | $3,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |